Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEVA-AFATINIB DIN 02514613

Status: Cancelled Pre Market
Holder: TEVA CANADA LIMITED
Molecule: AFATINIB (AFATINIB DIMALEATE)

Health Canada record

Active ingredient(s)AFATINIB (AFATINIB DIMALEATE) 40 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EB03 AFATINIB
Original market date
Current status date09-Apr-2025
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AFATINIB (AFATINIB DIMALEATE)

DINProductCompanyFormStrengthStatus
02415666GIOTRIFBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletAFATINIB (AFATINIB DIMALEATE) 20 MGMarketed
02415674GIOTRIFBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletAFATINIB (AFATINIB DIMALEATE) 30 MGMarketed
02415682GIOTRIFBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletAFATINIB (AFATINIB DIMALEATE) 40 MGMarketed
02517035MAR-AFATINIBMARCAN PHARMACEUTICALS INCTabletAFATINIB (AFATINIB DIMALEATE) 40 MGMarketed
02517019MAR-AFATINIBMARCAN PHARMACEUTICALS INCTabletAFATINIB (AFATINIB DIMALEATE) 20 MGMarketed
02517027MAR-AFATINIBMARCAN PHARMACEUTICALS INCTabletAFATINIB (AFATINIB DIMALEATE) 30 MGMarketed
02512777SANDOZ AFATINIBSANDOZ CANADA INCORPORATEDTabletAFATINIB (AFATINIB DIMALEATE) 20 MGMarketed
02512785SANDOZ AFATINIBSANDOZ CANADA INCORPORATEDTabletAFATINIB (AFATINIB DIMALEATE) 30 MGMarketed
02512793SANDOZ AFATINIBSANDOZ CANADA INCORPORATEDTabletAFATINIB (AFATINIB DIMALEATE) 40 MGMarketed
02514591TEVA-AFATINIBTEVA CANADA LIMITEDTabletAFATINIB (AFATINIB DIMALEATE) 20 MGCancelled Pre Market
02514605TEVA-AFATINIBTEVA CANADA LIMITEDTabletAFATINIB (AFATINIB DIMALEATE) 30 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
342042024-10-11Abbreviated New Drug Submission (ANDS)
Request a quote for TEVA-AFATINIB

How to read a Canadian DIN record